Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: Nifty MidSmall Healthcare Total Return Index
NAV: ₹12.21-0.78%
07 Jul 2026
Holdings Analysis
Equity, debt and cash allocation snapshot with market cap distribution for Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth.
Market Cap Distribution
Mid Cap (64.5%)
Small Cap (35.5%)
Historical Asset Allocation
| Asset | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Equity | 99.92% | 100.04% | 99.81% | 99.84% | 99.73% | 99.80% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 0.08% | -0.04% | 0.19% | 0.16% | 0.27% | 0.20% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Portfolio Snapshot
No. of Securities
31
P/E Ratio
40.00
P/B Ratio
4.78
Top Holding %
9.15%
Top 5 Holdings %
38.34%
Top 10 Holdings %
59.88%
AUM
₹35 Cr
Expense Ratio
0.76%
Since Inception
13.04%
Max Drawdown
-0.17%
Top Portfolio Holdings by Weight
Latest portfolio holdings sorted by allocation weight. Includes instrument name, sector, number of shares, market value (₹ Cr) and percentage of net assets. Switch dates or categories using the controls below.
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Lupin Ltd. | Healthcare | 13,986 | 3.17 | 9.15% | -0.73%↓ |
| Laurus Labs Ltd. | Healthcare | 22,441 | 3.06 | 8.82% | 1.25%↑ |
| Fortis Healthcare Ltd. | Healthcare | 30,057 | 2.79 | 8.05% | -0.45%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 16,120 | 2.3 | 6.63% | -0.24%↓ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 8,679 | 1.97 | 5.69% | -0.71%↓ |
| Alkem Laboratories Ltd. | Healthcare | 3,370 | 1.85 | 5.34% | -0.24%↓ |
| Biocon Ltd. | Healthcare | 41,165 | 1.76 | 5.09% | 0.55%↑ |
| Mankind Pharma Ltd. | Healthcare | 6,523 | 1.55 | 4.47% | -0.02%↓ |
| Ipca Laboratories Ltd. | Healthcare | 8,007 | 1.22 | 3.52% | -0.24%↓ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 14,241 | 1.08 | 3.12% | 0.21%↑ |
| Aster DM Healthcare Ltd. | Healthcare | 14,599 | 1.06 | 3.07% | -0.07%↓ |
| Gland Pharma Ltd. | Healthcare | 4,586 | 1.03 | 2.98% | 0.52%↑ |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | 4,718 | 1.02 | 2.95% | -0.00%↓ |
| Wockhardt Ltd. | Healthcare | 4,761 | 0.97 | 2.79% | 0.75%↑ |
| Sai Life Sciences Ltd. | Healthcare | 7,932 | 0.92 | 2.65% | 0.05%↑ |
| Neuland Laboratories Ltd. | Healthcare | 492 | 0.84 | 2.42% | 0.14%↑ |
| Abbott India Ltd. | Healthcare | 296 | 0.79 | 2.29% | -0.03%↓ |
| Narayana Hrudayalaya Ltd. | Healthcare | 3,980 | 0.75 | 2.17% | 0.01%↑ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 4,487 | 0.72 | 2.08% | 0.20%↑ |
| Ajanta Pharma Ltd. | Healthcare | 2,426 | 0.71 | 2.05% | -0.05%↓ |
1 / 2
Sector-wise Portfolio Allocation
Equity exposure by sector as a percentage of total net assets, tracked across recent portfolio dates. Identifies concentration risk and sector rotation trends in the fund's holdings.
| Sector | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Healthcare | 99.92% | 100.04% | 99.81% | 99.84% | 99.73% | 99.80% |
Equity Insights
A detailed look at the equity holdings of this scheme — aggregated scores on value, momentum, quality parameters along with diversification and performance analysis.
Style Analysis
Value score
27.3 / 100
Weighted average Value score is 27.3. This indicates that portfolio is relatively reasonably valued using composite of value measures.
Price Momentum score
79.3 / 100
Weighted average Price Momentum score is 79.3. This indicates that portfolio has high momentum using composite of momentum measures.
Quality score
82.7 / 100
Weighted average Quality score is 82.7. This indicates that portfolio has high quality using composite of quality measures.
QVM score
72.3 / 100
Weighted average QVM score is 72.3. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
Red Flags
Frequently Asked Questions
What are the top holdings of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth?
The top holdings of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth sorted by portfolio weight are listed in the Top Portfolio Holdings section of the Holdings tab.
How many stocks does Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth hold in its portfolio?
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth holds 31 securities in its portfolio. The top 5 holdings account for 38.34% of the portfolio and the top 10 for 59.88%.
What is the sector allocation of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth?
The sector allocation of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth is in the Sector Allocation section, showing each industry's weight in the portfolio.
What is the equity and debt allocation of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth?
As of 31 May 2026, Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth has 99.92% in equity, 0.00% in debt and 0.08% in cash/others. This asset mix determines the fund's overall risk-return profile.
What is the market cap allocation of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth?
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth's equity portfolio — Mid Cap: 64.46%, Small Cap: 35.54%. Market cap allocation determines the fund's risk profile — large cap offers stability while mid and small cap offer higher growth potential with higher volatility.
Is Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth a concentrated or diversified fund?
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth holds 31 securities, with the top 10 accounting for 59.88% of the portfolio and the top 5 for 38.34%. This is a moderately diversified fund balancing conviction positions with risk spread.
What is the credit quality of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth?
The credit quality breakdown of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth's debt portfolio is in the Credit Rating section. For equity-oriented funds, this section may not be applicable.
How often does Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth change its portfolio?
The portfolio currently holds 31 securities with the top 10 accounting for 59.88% as of 31 May 2026. Portfolio turnover reflects how actively the fund manager trades. A high turnover increases transaction costs while a low turnover reflects a buy-and-hold approach. Historical asset allocation snapshots across multiple dates are in the Holdings Analysis section.
What is the PE ratio of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth's portfolio?
The weighted average PE ratio of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth's portfolio is 40.00 and the PB ratio is 4.78. These metrics reflect the overall valuation and interest rate sensitivity of the portfolio.
When is the latest portfolio disclosure for Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth?
The latest portfolio disclosure for Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth is as of 31 May 2026. Mutual funds and ETFs in India are required to disclose their full portfolio monthly, within 10 business days of month-end. You can switch between historical disclosure dates using the date selector in the Top Portfolio Holdings section.